[ @entity101 XXXX : does not only occur at high blood pressure].

@entity1 @entity410 @entity227 @entity101 @entity1333 @entity75 @entity4 @entity391 @entity12661 @entity425 @entity177 @entity854 @entity1468 @entity911 @entity810 @entity751 @entity10 @entity631
A 45-year-old @entity1 presented with severe @entity101 , @entity10 , @entity12661 , and a depressed level of consciousness. A second @entity1 , a 33-year-old @entity1 , was admitted with @entity1468 . She developed lethargy, @entity10 , bilateral extensor plantar responses, and @entity410 . The third @entity1 , a 62-year-old @entity1 , presented with @entity810 due to @entity1333 and @entity631 . Five days after treatment with immunosuppressive drugs had been initiated, he developed @entity10 , @entity911 , @entity410 , and @entity12661 . @entity101 @entity75 is characterised by @entity10 , @entity391 , disturbances in cognition and level of consciousness, @entity227 , and @entity410 . Imaging studies often demonstrate @entity4 of the white matter in the posterior parietal and occipital areas of the brain. This so-called reversible posterior @entity751 is well known in @entity1 with severe @entity101 , but it is also associated with immunosuppressive drug use and @entity177 . It can be recognised by its fairly characteristic clinical features (different combinations of @entity10 , @entity391 , changes in cognition and level of consciousness, @entity410 , @entity425 , and @entity227 ) and by its specific imaging findings. Treatment consists of reducing the blood pressure and reducing or discontinuing the use of immunosuppressive drugs. If the treatment is started promptly, symptoms and @entity854 are usually reversible.
